Integrin Function and Signaling as Pharmacological Targets in Cardiovascular Diseases and in Cancer

E-ISSN： 1873-4286|11|16|2119-2134

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.16, 2005-01, pp. : 2119-2134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Integrin-Mediated Drug Delivery in Cancer and Cardiovascular Diseases with Peptide-Functionalized Nanoparticles

Current Medicinal Chemistry, Vol. 19, Iss. 19, 2012-07 ,pp. : 3128-3151

Bentham Science Publishers

Access to resources Recommend Favorite

Estrogen Receptors as Targets for Drug Development for Breast Cancer, Osteoporosis and Cardiovascular Diseases

Current Cancer Drug Targets, Vol. 4, Iss. 6, 2004-09 ,pp. : 483-499

Bentham Science Publishers

Access to resources Recommend Favorite

PPARs as Targets for Metabolic and Cardiovascular Diseases

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 8, 2005-08 ,pp. : 741-753

Bentham Science Publishers

Access to resources Recommend Favorite

Regulators of G Protein Signaling: Potential Drug Targets for Controlling Cardiovascular and Immune Function

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 2, 2004-06 ,pp. : 107-118

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases

Current Drug Targets, Vol. 18, Iss. 4, 2017-02 ,pp. : 463-472

Bentham Science Publishers

Access to resources Recommend Favorite